Li, 37 patient HCQ late treatment study: 40% slower viral clearance [p=0.06] https://c19p.org/li2
copied to clipboard
Treatment of COVID-19 patients with hydroxychloroquine or chloroquine: A retrospective analysis
et al., Research Square, doi:10.21203/rs.3.rs-119202/v1 (Preprint)
Small retrospective database analysis of 37 late stage patients hospitalized in an intensive care center in China, not finding a significant difference in viral shedding. Pateints were all in serious condition. There was only one death however the group is not specified. Confounding by indication is likely.
|
time to viral-, 40.0% higher, relative time 1.40, p = 0.06, treatment 18, control 19.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Li et al., 1/12/2021, retrospective, database analysis, China, Asia, preprint, 5 authors.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.